Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Gemcitabine|DRUG: Adriamycine|DRUG: Paclitaxel
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Eli Lilly and Company|Bristol-Myers Squibb